{"name":"Akcea Therapeutics","slug":"akcea-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQQWpnak9HQWowQXBPdEhfZE1LMEpQQndxM3VaYW5hNzItb0R4ZGtfNngtbzAyUVIwZ3MyRG9NUHAwVElwRktnSGt0RXFxVDBhV193R3R4aWF3Z1Y3MWZyMDVtd2xfU0ZrNGhUUGxmQ0pIQ2tBTkRRRi1YQm9ocGtEM2lrMUpjamhFYWtXak05RVgzb3lfRGdGN010U25JcUJueDhDQ2ZfSQ?oc=5","date":"2021-04-07","type":"deal","source":"fiercepharma.com","summary":"Ionis lays off majority of Akcea staff, expands Sobi Tegsedi deal - fiercepharma.com","headline":"Ionis lays off majority of Akcea staff, expands Sobi Tegsedi deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQLVE2MzBnUDlZMEVrVzJIT3RwbUhRdElxWmoxUnhlRUFDZTdfSU1iUC1mSHAxSm1RaWpxdzAxd0N6aW5BT1d1c3pxN2JtcGg2Vm1CU0ZmY0ltZDZVN0hvSjZDWTU0dGFpSTIzVGNjT3JQd1pBM3ZKMTNyd0FXVERxc3NDMHpmNVo4TVo3bGFTQ0dVZU1JX1ZkVTB4NGV0LUthQW42eG5Qcy02NWZFWDR1Zlp3?oc=5","date":"2021-04-07","type":"deal","source":"BioSpace","summary":"Ionis’ Ups and Downs: Partnership with Progenity, 70% Job Cuts at Akcea and More - BioSpace","headline":"Ionis’ Ups and Downs: Partnership with Progenity, 70% Job Cuts at Akcea and More","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPTWNLZy00NUZWd1doQVYzdXFiRGVQY3JKMmpvcVluNnpCRFBGOWd0ZTNIZHZBU096VUtUc0xWZVZmY0gydVhNUmswVXE5SEFrWm5zMjBUZG01RmFfT001RXh3WVdVS0dxcUd2R3V5bDBkdUtBSXFLVXZhalN3N3oxUEQzOHpjeTVlY0xGZDU0YzFpYnVqNFpYbnNzbUhOUk1DYWdXZ1VvaHpwampDUG1naGFMU1dDZzd5UEV3X3hB?oc=5","date":"2020-10-12","type":"pipeline","source":"PR Newswire","summary":"Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics - PR Newswire","headline":"Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE13YmhZZUNYQlRBVUxXMFB2X1VRVFR0NGs2TU5KT1AxbDdYN1ZGMFVyMDdhcERnRmotM2R5aWZfOExVbVNHQXNMYmJaZHlONWE4dTRpMFpRcnJfU3pMN0h1bWttWWJScjNHT01TVzZieW1XUEY3LVdj?oc=5","date":"2020-09-01","type":"regulatory","source":"Pharmaceutical Technology","summary":"Ionis agrees to take remaining stake in Akcea Therapeutics for $500m - Pharmaceutical Technology","headline":"Ionis agrees to take remaining stake in Akcea Therapeutics for $500m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNTkpjMjAwYURXeU5DLVhSekpiMEZkU21mNUhBdUxOZzVuOGdWYUY1ZUIydW1WTmd3QXpoX080bEdCQ1NsVVM4R0RJTDVLRlg1cHhTeHkyLTZoRVczVHVYekgyQWxKcmZnTWUwVjFQX25Od0h5WHZtQkNJYmY2TEVpMFg4a3Fqa3dJUnR6MnNZbmtsX2NNczBScjQ1MFY?oc=5","date":"2020-08-31","type":"deal","source":"Fierce Biotech","summary":"Ionis strikes deal to buy back lipid disease spinout Akcea - Fierce Biotech","headline":"Ionis strikes deal to buy back lipid disease spinout Akcea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNc3kyaTlLb3BLVmNPZzE0UnhvdjBLLXVPOF9fZUQ0d0Z2X0x0cU9hdlJwM2ZjVW1pcG9JS0xoSVE2cktlRWpJeU51RWtEYVlfOUpYYWRQeXNWSFkxckJhQmJXZDRCS25xYjBWcV9FcDR4a1ZqdHdsSG8yWFZFYzNGTDROWGdxbTNpM1FlOVZ4TzhpcjZydE8zdVlNSVdsMUxQQk5Xa3BySVZBZnlvd0hYQzgtN0pNdi1IbTZabmtBYkFBaXZM?oc=5","date":"2020-08-31","type":"regulatory","source":"PR Newswire","summary":"Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics - PR Newswire","headline":"Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNOTFLMElRUUVZbTNtY3A3NVRwU2YzSDItR0R1LUtfQlo1YW11cVZSeTdjYzBISV9XV2l6ZU5jQVRmd2NreV9EOF84dkFfOTRjTjdEbm80bHdROUJOTG9peW9YNnFzTlNHWTRIaFpSR3EtSTYxbXNFczAySjBTWlNLQ2FlRWJfVjhEUjZ1a2drZmhIRUl4TFotUW13aUkxdw?oc=5","date":"2019-09-23","type":"pipeline","source":"Fierce Biotech","summary":"Ionis CBO takes over Akcea as CEO, president and COO head out the door - Fierce Biotech","headline":"Ionis CBO takes over Akcea as CEO, president and COO head out the door","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPNGU1NTFmNWlnQ1M0SFMzSWduVXplMGxQeVppbW15eUpWWXpfZTcyckkwakRTRkVLQk4xNGV2STdscHNVR2VCTW5xTFJLS21IcEVieC1lN043Y2ZXYW5pMzFfVzk3UzBOV3ZseTdLdlppTHktbHYySWRLQ3hIcEU2S1NUaE9NaUphdHJxVzBHZXdkWnBhQUxlT1MteFBJT1FBN0FzLWF3?oc=5","date":"2019-02-26","type":"pipeline","source":"BioPharma Dive","summary":"Novartis moves forward on CV drug, paying $150M to Ionis, Akcea - BioPharma Dive","headline":"Novartis moves forward on CV drug, paying $150M to Ionis, Akcea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPVm9XMUJ0aFhKem5qVndzdnJsdk8zSFhYLUxDRWozMmNHeXhGdFd1My1VNFZ6QmhyQ2lXSDNXSS1ZN29uMFh5Vy01anVCeklxWFcweXFNZThFQ2o1WW03RXI3dUJlY2FhTUdIOHlsUzg0ZXZmX1B1LWoxdlpPWjlXNlVmMGN5UQ?oc=5","date":"2018-10-05","type":"regulatory","source":"BioPharma Dive","summary":"FDA clears rare disease therapy from Akcea, Ionis - BioPharma Dive","headline":"FDA clears rare disease therapy from Akcea, Ionis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNQ01SSjdZQV9POE1qQVo2NXlUQkJPeFl2clc5anExd2lpemhTQnpJZ2dzMEQyRTRIREFMUF8wZExtb241VFJ2dnAtWHpnWk9pOVdzcS1pQnFBWXFhYVNwaU1VdTFZZ24yUHB5dGJaU3NpdFFWZzVfRVJXREI3bHFOT3ZVdVNEM3loY2RqNHpHMEJldi1xS25FQw?oc=5","date":"2018-08-29","type":"pipeline","source":"Yahoo Finance Australia","summary":"Can Akcea Therapeutics, Inc. and Ionis Pharmaceuticals, Inc. Recover? - Yahoo Finance Australia","headline":"Can Akcea Therapeutics, Inc. and Ionis Pharmaceuticals, Inc. Recover?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOaTlncTMwY0lwakFWV201UDA4NmRXNDhtdF96Szh0RlhPZnVRaG9jZHZCSGVUM3Nmbi1XT2FybmtDQWR1TXNIdjZqZDZHTFA1eGJBMHBTWFlXYnh5Ym40cHpBZDh4eXRNV1F3MEZvWWJ0WTBwcGNMRGhOckVzdkxtTFVJN25jVVpieGFWWFZ3bnNPYk1oZGQ5azI0U1Zxdw?oc=5","date":"2018-08-28","type":"pipeline","source":"The Motley Fool","summary":"Here's Why Ionis Pharmaceuticals and Akcea Therapeutics Plummeted Today - The Motley Fool","headline":"Here's Why Ionis Pharmaceuticals and Akcea Therapeutics Plummeted Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPcEVodjdpTTVORjJ5ajJXX2JfUHNDTE1MQ19Zam9vVGZNWmFaUXE4bXZlYml0QVc1R0puUWF0SV94MHByTGJkdXBNY2VwdEoxRmdOY2JVb252MVVpdHNVVXlnR1hudTJDelNwOHNCRzBEcVB1UUF5bHlEWFRLaGQwblJCUVRkV2lOcWpMUV9CcFkyZ1J5OGMxMnpWck5CNWFHcEd0T1BKY3VrVWtlUXVHQw?oc=5","date":"2018-03-15","type":"deal","source":"BioSpace","summary":"Ionis Pharmaceuticals Partners With Akcea Therapeutics in a Potential $1.7 Billion Deal - BioSpace","headline":"Ionis Pharmaceuticals Partners With Akcea Therapeutics in a Potential $1.7 Billion Deal","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}